| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.29 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |